Skip to main
DLB
DLB logo

Dolby Laboratories (DLB) Stock Forecast & Price Target

Dolby Laboratories (DLB) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Dolby Laboratories Inc. reported total revenues of $307.0 million, reflecting a year-over-year increase of approximately 1%, which aligns with estimates. The company demonstrated improved operating margins, rising to 33.2% for the full year compared to 31.2% in the previous fiscal year, while total revenue for the year grew 5.9%, driven by a 5.6% increase in license revenue and a notable 10% rise in product and services revenue. With the ongoing adoption of its technologies and the expansion of the premium large format (PLF) cinema concept, Dolby is well-positioned for sustained growth, bolstered by strong demand for its Dolby Vision capture technology in key markets like China and India.

Bears say

Dolby Laboratories is projecting a high-single-digit revenue decline for fiscal 2026, reflecting a continued trend similar to fiscal 2025, raising concerns about the company’s growth potential. Management's revised growth expectations for the Atmos/Vision/Patents business have also been lowered, now projected at 15% to 20%, down from a previous range of 15% to 25%. Additionally, gross margins experienced a slight decline from 90.1% to 89.7%, indicating potential challenges in maintaining profitability amidst a difficult macroeconomic environment and weakening foundational revenues linked to device volumes.

Dolby Laboratories (DLB) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Dolby Laboratories and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Dolby Laboratories (DLB) Forecast

Analysts have given Dolby Laboratories (DLB) a Buy based on their latest research and market trends.

According to 4 analysts, Dolby Laboratories (DLB) has a Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $92, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $92, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Dolby Laboratories (DLB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.